Mapp Biopharmaceutical was founded in 2003 by Drs. Kevin Whaley and Larry Zeitlin to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

Learn more:

It’s with great sadness that our friend and colleague Bill passed away unexpectedly in 2022.  We are grateful to be able to include Bill in this video. We miss his smile, kindness, and scientific curiosity.